Inactive Instrument

Other languages Benitec Biopharma Limited Australian S.E.

Equities

BLT

AU000000BLT8

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Benitec Biopharma Inc. Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study	Apr. 18
Benitec Biopharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 13
Benitec Biopharma Doses First Participant in Trial of Treatment for Oculopharyngeal Muscular Dystrophy	Nov. 30
Benitec Biopharma Announces First Subject Dosed in Phase 1B/2A Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy	Nov. 30
Benitec Biopharma Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 13
Benitec Biopharma Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-21
Sector Update: Health Care Stocks Gaining in Late Afternoon Trading	23-08-11
Sector Update: Health Care	23-08-11
Benitec Biopharma Completes $30.9 Million Public Offering	23-08-11
Top Midday Gainers	23-06-26
Benitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy	23-06-26
Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-15
Benitec Biopharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-13
Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program	23-01-23
Benitec Biopharma Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-10
Benitec Biopharma Prices $17.9 Million Public Offering	22-09-13
Benitec Biopharma Receives Nasdaq Notice for Non-Compliance With Minimum Bid Price Rule	22-09-08
Benitec Biopharma Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-02
Benitec Biopharma Inc. Auditor Raises 'Going Concern' Doubt	22-09-01
Earnings Flash (BNTC) BENITEC BIOPHARMA Posts Q3 Revenue $48,000	22-05-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Benitec Biopharma Limited Australian S.E.

Equities

BLT

AU000000BLT8

Other languages

Filters